Previous 10 | Next 10 |
2023-10-31 16:22:29 ET More on PROS Holdings PROS Holdings may be worth low $40s a share in a takeover - analyst PROS Holdings jumps amid report of takeover interest Seeking Alpha’s Quant Rating on PROS Holdings Historical earnings data for PROS Holdin...
Tennant Company (TNC) is expected to report for Q3 2023 Stellantis N.V. (STLA) is expected to report for Q3 2023 Marathon Petroleum Corporation (MPC) is expected to report $7.79 for Q3 2023 Easterly Government Properties Inc. (DEA) is expected to report $0.29 for Q3 2023 Allegion ...
PROS Holdings Inc. (PRO) is expected to report $-0.15 for Q3 2023
2023-10-16 10:25:35 ET More on ProKidney REACT Or Retreat: ProKidney's Phase 3 Focal Point For further details see: Prokidney says Palihapitiya Chamath sells ~486.9K shares
PROS ® (NYSE: PRO), a leading provider of AI-powered SaaS pricing, CPQ, revenue management, and digital offer marketing solutions, will release its financial results for the third quarter 2023 ended September 30, 2023 after the U.S. financial markets close on Tuesday, October 31, 2023. ...
2023-09-28 15:45:21 ET More on PROS Holdings PROS Holdings, Inc. (PRO) Q2 2023 Earnings Call Transcript PROS Holdings Sees Strong Travel Activity But Slower Growth In 2023 PROS Holdings jumps amid report of takeover interest Seeking Alpha’s Quant Ratin...
2023-09-27 14:58:39 ET More on Technology Select Sector Energy (XLE) Vs. Tech (XLK) Is Like Djokovic Vs. Federer Tech Stocks Aren't Done: Strong Buy On XLK Energy In, Tech Out Technology Select Sector SPDR ETF declares quarterly distribution of $0.3603 ...
2023-09-27 10:01:07 ET More on PROS Holdings PROS Holdings, Inc. (PRO) Q2 2023 Earnings Call Transcript PROS Holdings Sees Strong Travel Activity But Slower Growth In 2023 Seeking Alpha’s Quant Rating on PROS Holdings Historical earnings data for PROS ...
2023-09-05 08:42:44 ET Insmed Incorporated ( NASDAQ: INSM ) added ~7% pre-market Tuesday after announcing that a Phase 3 trial for its antibiotic Arikayce reached the main goal in adults with a type of bacterial lung infection. The Phase 3b placebo-controlled trial involved ...
PROS Holdings, Inc. (NYSE: PRO), a leading provider of AI-powered SaaS pricing, CPQ, revenue management, and digital offer marketing solutions, today announced that company management will participate in the following investment conferences in August 2023. KeyBanc Technology Leadership Fo...
News, Short Squeeze, Breakout and More Instantly...
2024-08-03 00:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
PROS Holdings, Inc. (NYSE: PRO), a leading provider of AI-powered SaaS pricing, CPQ, revenue management, and digital offer marketing solutions, today announced that company management will participate in the following investor conferences in August 2024. KeyBanc Capital Markets Technology...
Subscription revenue of $65.6 million, up 14% year-over-year. Subscription gross margin of 78% and non-GAAP subscription gross margin of 80%, an improvement of more than 160 basis points year-over-year. Improved operating cash flow by $13.0 million, or nearly 200%, year-over-year. ...